Journal profile · Biochemistry, Genetics and Molecular Biology-Cancer Research
Journal of Gastric Cancer
ISSN 2093-582X · eISSN 2093-5641 · Korean Gastric Cancer Association · South Korea
Journal of Gastric Cancer: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 5; fully open access; APC about USD 3,000; median 71 days to acceptance (76 articles, last 24 months); 48 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Gastric Cancer is published by Korean Gastric Cancer Association and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment and Metastasis and carcinoma case studies, together about 54.6% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Gastric Cancer (J Gastric Cancer) is an international peer-reviewed journal. Each issue carries high quality clinical and translational researches on gastric neoplasms. Editorial Board of J Gastric Cancer publishes original articles on pathophysiology, molecular oncology, diagnosis, treatment, and prevention of gastric cancer as well as articles on dietary control and improving the quality of life for gastric cancer patients. J Gastric Cancer includes case reports, review articles, how I do it articles, editorials, and letters to the editor. The process of review and screening of submitted articles is through online (https://jgc-online.org), which enable to decrease time for the assessment and publication. Please refer to "instructions for authors" for detailed information regarding submissions. J Gastric Cancer is dedicated to provide recent researches on new information for treating gastric cancer, by extension, to improve public health. All or some of the articles in this journal are indexed in KCI, KoreaMed, KoMCI, KoreaMed Synapse, MEDLINE, PubMed, PMC, Scopus, and Science Citation Index Expanded (SCIE, Web of Science). Full text is available from https://jgc-online.org. For subscription and all other information, visit our website (https://jgc-online.org).
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Cancer Research
Editor-in-chief Han Hong LeePublisher website
Editorial board by country: 1 in mainland China (about 2%); most named South Korea 33, Japan 6, Hong Kong, China 2, United States 2, Mainland China 1 (57 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Gastric Cancer Management and OutcomesMedicine33.9%
- Gastrointestinal Tumor Research and TreatmentMedicine12.2%
- Metastasis and carcinoma case studiesMedicine8.6%
- Esophageal Cancer Research and TreatmentMedicine7.7%
- Helicobacter pylori-related gastroenterology studiesMedicine6.7%
- Esophageal and GI PathologyMedicine3.2%
- Bariatric Surgery and OutcomesMedicine3.1%
- Gastrointestinal disorders and treatmentsMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCPubMedPublisher website
Other: Google Scholar, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5LetPub ·
- Impact factor (publisher) 2025
- 3.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 20Publisher website ·
- CiteScore 2026-06
- 7.8LetPub ·
- CiteScore (publisher) 2025
- 1.49Publisher website ·
- SJR 2026-06
- 1.49LetPub ·
- SJR (publisher) 2025
- 5.1Publisher website ·
- SNIP 2026-06
- 1.42LetPub ·
- h-index
- 22LetPub ·
- h-index
- 50OpenAlex ·
- i10-index
- 376OpenAlex ·
- 2-year mean citedness
- 5.81OpenAlex ·
- Self-citation rate
- 21.6%LetPub ·
- Share of gold OA articles
- 96.3%LetPub ·
Volume
- Articles per year
- 36LetPub ·
Articles by year OpenAlex count · 1,087 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 43 | 43 | 36 |
| 2025 | 48 | 48 | 345 |
| 2024 | 42 | 42 | 392 |
| 2023 | 44 | 44 | 747 |
| 2022 | 37 | 37 | 509 |
| 2021 | 40 | 40 | 540 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
71 daysMedian, submission to acceptance · P25–P75 40 days – 109 days
- Acceptance to online
- median 31 days (76 articles)
- Submission to online
- median 101 days
- Sample
- 76 articles with submission and acceptance dates (93 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 4 daysPublisher website ·
- Acceptance to publication
- 30 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | USD 3,000 / USD 2,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- Vancouver
- Graphical abstract
- Optional
Article types accepted6
- case reportsCase reports: Only the cases that are reported for the first time or collections of rare cases are accepted for reviewed.Length not stated
- editorialsEditorials: Editorials are invited articles that accompany the original article for publication.Length not stated
- how i do itHow I do it: These brief reports describe an author's revolutionary clinical or research technique that simplifies the procedures or improves the outcome of tre…Length not stated
- letter to the editorLetter to the editor: Letters to the editor are brief reports related to articles published in J Gastric Cancer.Length not stated
- original articlesOriginal articles: Original articles are full-length reports on basic and clinical investigations of neoplasms of the stomach.Length not stated
- review articlesReview articles: Review articles are usually requested by the Deputy Editor.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Peer review, Plagiarism
- AI use
AI tools allowed as assistive resource; use must be disclosed; AI cannot be an author. Model summary
Authors may use artificial intelligence (AI)–based tools to support manuscript preparation; however, such tools must be used only as an assistive resource and must not replace the authors’ own critical thinking, interpretation, and scientific judgment.
Source ↗Publisher website ·- Authorship 5) Authorship
Authorship of the manuscript submitted in J Gastric Cancer should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically; or 3) final approval of the version to be published. Authors must meet at least one of these 3 conditions. 6) Originality and duplicate publication All sub…
Source ↗Publisher website ·- Conflicts of interest 1) Conflict of interest statement
If there are any conflicts of interest, authors should disclose them in the manuscript. 2) Statement of informed consent Copies of written informed consent and IRB approval for clinical research should be maintained. If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB approval and study conduct. 3) Statement of human and animal rights Clinical…
Source ↗Publisher website ·- License & copyright
Copyright transferred to J Gastric Cancer on acceptance. Model summary
On acceptance, all authors should transfer copyright of the article to J Gastric Cancer.
Source ↗Publisher website ·- Peer review
Peer review: single anonymized, typically three reviewers per manuscript. Model summary
All submitted manuscripts are subject to editorial peer review. Our journal’s review process is conducted in a single anonymized manner, and typically, three reviewers are assigned to each manuscript.
Source ↗Publisher website ·- Plagiarism 5. Similarity Check
Similarity screening with iThenticate. Model summary
Similarity Check is a multi-publisher initiative to screen published and submitted content for originality. To find out more about Similarity Check, visit https://crossref.org/services/similarity-check/. All manuscripts submitted to the Journal of Gastric Cancer may be screened, using the iThenticate tool, for textual similarity to other previously published works. 6. References 1) International C…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Korean Gastric Cancer Association
- Country or region
- South Korea
- Language
- English
- ISSN
- 2093-582X
- Electronic ISSN
- 2093-5641
- Society / sponsor
- Korean Gastric Cancer Association
- Latest issue on the website
- Volume 26, Issue 3 (July 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Journal of Gastric Cancer
What CAS zone is Journal of Gastric Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Gastric Cancer is in Zone 4 of Medicine, and in Zone 4 of the minor category Gastroenterology & Hepatology / Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Gastric Cancer?
The latest impact factor listed by LetPub is 5; CiteScore 7.8, h-index 50.
How long does peer review take at Journal of Gastric Cancer?
Based on the dates recorded on 76 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 71 days (interquartile range 40–109 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Gastric Cancer?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: Vancouver; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Gastric Cancer based?
Of the 57 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are South Korea (33), Japan (6) and Hong Kong, China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Gastric Cancer?
According to LetPub and DOAJ records, Journal of Gastric Cancer is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PMC and PubMed; that list has not been checked against each database.
Is Journal of Gastric Cancer open access, and what is the APC?
Journal of Gastric Cancer is a fully open-access journal. APC about USD 3,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .